Monday, May 27, 2013

Pramod Gupta, PhD with Spectrum Pharmaceuticals - Biotech Success Story Friday, October 26, 2012

Pramod Gupta, PhD, SVP of Pharmaceutical Operations at Spectrum Pharmaceuticals will be speaking on "Research Opportunities in Current Health Care Environment".
Friday, October 26th (Nevada Day)
11:30 check-in, 12 pm Lunch & Talk
McCormick & Schmicks
$30 RSVP here
(UNLV Students & Researchers - free! Please RSVP)

Spectrum Pharmaceuticals (SPPI) is a biotechnology company with a primary focus in oncology and hematology. Its headquarters is in Henderson, Nevada.

Spectrum has three oncology drugs in the market: FUSILEV® (levoleucovorin), FOLOTYN® (pralatrexate injection) and ZEVALIN® (ibritumomab tiuxetan).

Spectrum has an expertise in acquiring differentiated drugs and a growing pipeline of candidates in Phase 2 and Phase 3 trials (10 drugs in the pipeline).


Spectrum Pharmaceuticals is one of the fastest growing companies in biotechnology. It has a massive pipeline, two marketed drugs, and is very cash rich. (Brian Nichols, Sept 2, 2012 Seeking Alpha). Spectrum's revenues are expected to increase by 50% to $300 million in 2012.

1 comment:

Anonymous said...

If some one needs too be updated with newest technologies after that he
must be pay a quick visit this web page and be up to date
everyday.

Have a look at my blog - risingtidebook karaoke songs